Significance of ERα, HER2, and CAV1 expression and molecular subtype classification to canine mammary gland tumor.
Canine mammary gland tumor (CMT) and human breast cancer (HBC) share many similarities regarding their risk factors, histological features, and behavior. Despite the increasing evidence of molecular marker expression as a prognostic indicator for HBC, few studies have applied this approach to CMT. The aim of the present study is to evaluate the significance of the expression of estrogen receptor-alpha (ERα), human epidermal growth factor receptor 2 (HER2), and caveolin-1 (CAV1) to the behavior and the clinical outcome of CMT. Additionally, the correlation between subtype classification (luminal A, luminal B, HER2-overexpressing, basal-like, and normal-like) and tumor behavior prognosis were assessed. Canine mammary gland tissues were immunohistochemically stained for ERα, HER2, and CAV1 and evaluated and classified into 5 subtypes on the basis of immunoreactivity. Although there were no statistically significant differences in the molecular marker immunoreactivity of different subtypes, the degree of positive staining for ERα, extranuclear ERα, HER2, and CAV1 showed significant correlations (P < 0.05) with the behavior and prognosis of the tumor. The current study indicates the prognostic value of immunohistochemical staining status of ERα, HER2, and CAV1 for CMT. In addition, some trends were seen in subtype classification on the prognosis of the tumor, implying that, although further analysis is needed, there is potential clinical application of 5-subtype classification for CMT.
College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO.
Hitomi
H
Shinoda
College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO.
Marie E
ME
Legare
College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO.
Gary L
GL
Mason
College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO.
Jennifer L
JL
Berkbigler
College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO.
Maryam F
MF
Afzali
College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO.
Alfred F
AF
Flint
College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO william.hanneman@colostate.edu.
William H
WH
Hanneman
Canine; immunohistochemical staining; mammary gland; molecular subtype.